Tag: plant-derived analgesics market demand

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Plant-Derived Analgesics Market Size Forecast: How Large Could The Market Become By 2030?

The plant-derived analgesics market size has shown strong growth in recent years. It is anticipated to expand from $3.39 billion in 2025 to $3.66 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%. The expansion observed in the historic period stems from factors such as traditional medicine adoption, the demand for natural pain relief, an increase in herbal supplement use, concerns regarding opioid side effects, and the broadening of botanical extraction practices.

The plant-derived analgesics market is projected to experience substantial expansion in the coming years. This market is forecast to reach a valuation of $5.06 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. This anticipated growth is driven by several factors, including a growing preference for natural therapeutic options, the development of cannabinoid-based medicines, the increasing pipeline of plant-based drugs, enhanced clinical validation of botanical remedies, and the broader integration of holistic care practices. Key trends during this period are expected to include the development of standardized botanical pain extracts, the isolation of high-purity phytochemicals, the creation of combination herbal analgesic formulations, improvements in the bioavailability of plant-derived active compounds, and the proliferation of evidence-based botanical therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33264&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Plant-Derived Analgesics Market Opportunity Drivers: What Is Creating New Revenue Potential?

The growing occurrence of chronic pain conditions is anticipated to boost the expansion of the plant-derived analgesics market in the coming years. These persistent pain disorders encompass musculoskeletal pain, arthritis, neuropathic pain, and various inflammatory conditions, all necessitating continuous pain management. The worldwide prevalence of chronic pain is increasing, driven by factors such as aging demographics, inactive lifestyles, rising obesity rates, and the expanding burden of chronic illnesses. Plant-derived analgesics offer support in managing these conditions by providing pain relief derived from botanical extracts, herbs, and active plant compounds, which are increasingly adopted as supplementary or alternative pain management strategies. For example, data from November 2024, released by the Centers for Disease Control and Prevention (CDC), a federal public health agency based in the US, indicated that approximately 24.3% of adults in the United States suffered from chronic pain in 2023, with 8.5% experiencing high-impact chronic pain. Consequently, the escalating prevalence of chronic pain conditions across key healthcare markets is propelling the growth of the plant-derived analgesics market. The increasing consumer inclination towards natural remedies is set to drive the growth of the plant-derived analgesics market moving forward. Natural remedies are defined as treatments sourced from natural elements like plants, herbs, minerals, and animal products, utilized for preventing, managing, or alleviating health conditions. They are frequently linked with traditional, herbal, and complementary medicine practices, often serving as alternatives or adjuncts to conventional medical therapies. This preference for natural solutions is primarily escalating due to enhanced consumer awareness of holistic and plant-based healthcare approaches, alongside concerns about the side effects and prolonged use of synthetic medications. Plant-derived analgesics align with this trend by supplying pain relief options originating from medicinal plants, thereby satisfying consumer demand for plant-based and perceived safer therapeutic alternatives. As an illustration, in September 2025, the American Botanical Council (ABC), a US-based nonprofit educational and research body, reported that retail sales of herbal dietary supplements in the United States hit a record $13.231 billion in 2024. This represented an additional $680 million spent by U.S. consumers on herbal supplements compared to 2023, marking a 5.4% year-over-year increase. Hence, the rising consumer preference for natural remedies is significantly contributing to the expansion of the plant-derived analgesics market.

Plant-Derived Analgesics Market Segmentation Trends And Revenue Drivers

The plant-derived analgesics market covered in this report is segmented –

1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin

2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils

3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals

4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets

5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain

Subsegments:

1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms

2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations

3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations

4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts

5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms

Plant-Derived Analgesics Market Innovation Trends Driving Future Development

Leading companies within the plant-derived analgesics market are concentrating on technological advancements in botanical extraction, purification, and formulation techniques, including approaches for plant-based formulation and bioavailability enhancement. This focus aims to reduce batch-to-batch variability and improve both regulatory and consumer acceptance. Plant-based formulation and bioavailability enhancement specifically refer to the scientific optimization of plant-derived analgesic products through advanced formulation strategies, designed to improve the stability, solubility, and absorption of bioactive botanical compounds, thereby supporting more consistent product performance and enhanced therapeutic delivery. For instance, in January 2023, Medterra CBD, LLC., a US-based botanical wellness company, launched its Natural Pain Relief capsules to expand consumer access to plant-based pain management solutions. These Natural Pain Relief capsules are positioned as a plant-based, non-opioid pain management option, formulated with standardized botanical ingredients such as turmeric and Levagen+ palmitoylethanolamide (PEA), with the objective of enhancing bioavailability and providing relief from muscle pain, joint stiffness, and inflammation.

#Plant-Derived Analgesics Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited

Access The Complete Plant-Derived Analgesics Market Report:

https://www.thebusinessresearchcompany.com/report/plant-derived-analgesics-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

Plant-Derived Analgesics Market Global Footprint: Which Region Holds Market Leadership?

North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Increase In Market Value Is Predicted For The Plant-Derived Analgesics Market During The 2026–2030 Period?

The plant-derived analgesics market has seen considerable growth in recent years. It is projected to increase from $3.39 billion in 2025 to $3.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion can be attributed to the uptake of traditional medicine, a rising demand for natural pain relief options, the growing use of herbal supplements, concerns regarding the side effects of opioids, and the broader development of botanical extraction techniques.

The plant-derived analgesics market size is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $5.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. This projected expansion can be attributed to several factors such as the increasing preference for natural therapeutics, the growth of cannabinoid medicines, the broadening of plant-based drug pipelines, enhanced clinical validation of botanicals, and the wider adoption of integrative care. Furthermore, major trends foreseen during this period include standardized botanical pain extracts, the isolation of high-purity phytochemicals, the development of combination herbal analgesic formulas, plant actives with enhanced bioavailability, and evidence-based botanical therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33264&type=smp

Which Drivers Are Advancing The Plant-Derived Analgesics Market Growth?

The growing occurrence of chronic pain conditions is anticipated to fuel the expansion of the plant-derived analgesics market in the future. These persistent pain disorders, encompassing musculoskeletal pain, arthritis, neuropathic pain, and inflammatory conditions, necessitate continuous management. The global increase in chronic pain is attributed to factors such as aging populations, inactive lifestyles, rising obesity levels, and a greater incidence of chronic illnesses. Plant-derived analgesics aid in managing these conditions by providing pain relief solutions created from botanical extracts, herbs, and bioactive plant compounds, which are increasingly adopted as complementary or alternative pain therapies. For example, data from November 2024, supplied by the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, indicated that approximately 24.3% of adults in the United States suffered from chronic pain in 2023, with 8.5% experiencing high-impact chronic pain. Consequently, the escalating prevalence of chronic pain conditions across key healthcare markets is boosting the plant-derived analgesics market’s growth.

What Key Segment Areas Are Included In The Plant-Derived Analgesics Market Assessment?

The plant-derived analgesics market covered in this report is segmented –

1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin

2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils

3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals

4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets

5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain

Subsegments:

1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms

2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations

3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations

4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts

5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms

Which Trends Are Influencing The Direction Of The Plant-Derived Analgesics Market?

Key companies operating in the plant-derived analgesics market are increasingly concentrating on technological progress in botanical extraction, purification, and formulation methodologies, including plant-based formulation and bioavailability enhancement. This focus aims to diminish batch-to-batch inconsistencies and improve both regulatory and consumer acceptance. Plant-based formulation and bioavailability enhancement denote the scientific optimization of analgesic products derived from plants, utilizing advanced formulation strategies crafted to improve the stability, solubility, and absorption of active botanical compounds, thereby ensuring more reliable product performance and enhanced therapeutic delivery. As an illustration, in January 2023, Medterra CBD, LLC., a US-based botanical wellness firm, launched its Natural Pain Relief capsules to broaden consumer access to plant-based solutions for pain management. The Natural Pain Relief capsules are positioned as a plant-derived, non-opioid pain management choice, formulated with standardized botanical ingredients such as turmeric and Levagen+ palmitoylethanolamide (PEA), with the intention of boosting bioavailability and assisting in the relief of muscle pain, joint stiffness, and inflammation.

Which Key Players Are Active In The Plant-Derived Analgesics Market?

Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited

Access The Complete Plant-Derived Analgesics Market Report:

https://www.thebusinessresearchcompany.com/report/plant-derived-analgesics-market-report

Which Region Is The Primary Market For The Plant-Derived Analgesics Market?

North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Plant-Derived Analgesics Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Plant-Derived Analgesics Market In 2026, And How Will Its Value Evolve By 2030?

The plant-derived analgesics market has experienced robust growth in recent years. It is anticipated to expand from $3.39 billion in 2025 to $3.66 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. This historical expansion can be linked to factors such as the adoption of traditional medicine, a rising demand for natural pain relief, increased usage of herbal supplements, concerns over opioid side effects, and the growth in botanical extraction techniques.

The plant-derived analgesics market size is projected for substantial expansion over the upcoming years. This market is anticipated to reach $5.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.4%. The anticipated increase during this period stems from factors such as a growing inclination towards natural therapeutics, the advancement of cannabinoid medicines, the broadening of plant-based drug pipelines, enhanced clinical validation of botanicals, and a broader embrace of integrative care. Key developments expected in the forecast period encompass standardized botanical pain extracts, the isolation of high purity phytochemicals, the development of combination herbal analgesic formulas, advancements in plant actives for enhanced bioavailability, and the adoption of evidence-based botanical therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33264&type=smp

What Key Factors Are Shaping The Plant-Derived Analgesics Market Landscape?

The rising occurrence of chronic pain conditions is projected to drive the expansion of the plant-derived analgesics market in the coming years. Chronic pain conditions encompass persistent pain disorders such as musculoskeletal pain, arthritis, neuropathic pain, and inflammatory issues that demand ongoing management. The global increase in chronic pain is attributed to factors like aging populations, sedentary lifestyles, rising obesity rates, and the growing burden of chronic diseases. Plant-derived analgesics contribute to managing these conditions by offering pain relief options derived from botanical extracts, herbs, and active plant compounds, which are increasingly adopted as complementary or alternative approaches for pain management. For instance, in November 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, indicated that about 24.3% of adults in the United States experienced chronic pain in 2023, with 8.5% reporting high-impact chronic pain. Thus, the growing prevalence of chronic pain conditions in major healthcare markets is fueling the growth of the plant-derived analgesics market.

Which Segment Types Are Examined In The Plant-Derived Analgesics Market Segment Study?

The plant-derived analgesics market covered in this report is segmented –

1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin

2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils

3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals

4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets

5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain

Subsegments:

1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms

2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations

3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations

4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts

5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms

What Market Trends Are Affecting The Plant-Derived Analgesics Market?

Major companies in the plant-derived analgesics market are increasingly focusing on technological advancements in techniques for botanical extraction, purification, and formulation, including plant-based formulation and bioavailability enhancement. This effort aims to reduce variability from batch to batch and enhance both regulatory acceptance and consumer confidence. Plant-based formulation and bioavailability enhancement specifically refer to the scientific optimization of plant-derived analgesic products through advanced formulation approaches designed to improve the stability, solubility, and absorption of bioactive botanical compounds, thereby supporting more consistent product performance and improved therapeutic delivery. For instance, in January 2023, Medterra CBD, LLC., a US-based botanical wellness company, launched its Natural Pain Relief capsules, expanding consumer access to plant-based pain management solutions. These Natural Pain Relief capsules are presented as a plant-based, non-opioid pain management option, formulated with standardized botanical ingredients such as turmeric and Levagen+ palmitoylethanolamide (PEA), with the goal of enhancing bioavailability and providing relief from muscle pain, joint stiffness, and inflammation.

Which Players Are Part Of The Competitive Landscape Of The Plant-Derived Analgesics Market?

Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited

Get The Full Plant-Derived Analgesics Market Report:

https://www.thebusinessresearchcompany.com/report/plant-derived-analgesics-market-report

Which Region Is The Top Contributor To The Plant-Derived Analgesics Market By Share?

North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Plant-Derived Analgesics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=33264&type=smp

Browse Through More Reports Similar to the Global Plant-Derived Analgesics Market 2026, By The Business Research Company

Analgesics Market Report 2026

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Topical Pain Relief Market Report 2026

https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Plant-Derived Analgesics Market Evolve From 2026 To 2030?

The plant-derived analgesics market has experienced robust growth in recent years. Its value is expected to rise from $3.39 billion in 2025 to $3.66 billion in 2026, at a compound annual growth rate (CAGR) of 8.2%. This expansion during the preceding period can be attributed to factors such as the adoption of traditional medicine, the increasing demand for natural pain relief, a rise in herbal supplement usage, concerns regarding the side effects of opioids, and the wider application of botanical extraction techniques.

The plant-derived analgesics market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $5.06 billion in 2030, driven by a compound annual growth rate (CAGR) of 8.4%. This anticipated growth during the projection period stems from a heightened inclination towards natural therapeutic options, the expansion of cannabinoid-based medications, an increase in plant-based drug development pipelines, greater clinical endorsement of botanical remedies, and broader adoption of integrative care approaches. Key developments expected within this period encompass standardized botanical extracts for pain relief, the isolation of high-purity phytochemicals, the formulation of combination herbal analgesics, plant active compounds with improved bioavailability, and botanical therapies grounded in evidence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33264&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Plant-Derived Analgesics Market?

The expanding occurrence of chronic pain conditions is anticipated to boost the growth of the plant-derived analgesics market in the coming years. These persistent pain disorders, which encompass musculoskeletal pain, arthritis, neuropathic pain, and inflammatory conditions, necessitate continuous pain management. The global increase in chronic pain is attributed to aging populations, inactive lifestyles, rising obesity levels, and a greater incidence of chronic diseases. Plant-derived analgesics facilitate the management of these conditions by providing pain relief derived from botanical extracts, herbs, and plant-based bioactive compounds, which are increasingly adopted as complementary or alternative pain therapies. For example, data from November 2024 from the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, indicated that approximately 24.3% of adults in the United States suffered from chronic pain in 2023, with 8.5% experiencing high-impact chronic pain. Consequently, the rising frequency of chronic pain conditions across key healthcare markets is fueling the expansion of the plant-derived analgesics market. The escalating consumer inclination towards natural remedies is projected to drive the expansion of the plant-derived analgesics market in the foreseeable future. Natural remedies encompass treatments originating from natural sources like plants, herbs, minerals, and animal products, utilized for preventing, managing, or alleviating various health conditions. These are frequently linked to traditional, herbal, and complementary medicine practices, often serving as alternatives or complements to conventional medical treatments. This growing preference for natural solutions stems largely from increased consumer awareness of wellness-focused and plant-based healthcare methods, alongside apprehension about the side effects and prolonged use of synthetic medications. Plant-derived analgesics cater to this demand by providing pain relief options derived from medicinal plants, thereby addressing the consumer desire for plant-based and seemingly safer therapeutic choices. For example, in September 2025, the American Botanical Council (ABC), a US-based nonprofit educational and research organization, reported that retail sales of herbal dietary supplements in the United States reached an unprecedented $13.231 billion in 2024. This represented an increase of $680 million in U.S. consumer spending on herbal supplements compared to 2023, marking a 5.4% year-over-year growth. Thus, the increasing consumer preference for natural remedies is propelling the growth of the plant-derived analgesics market.

Which Segment Areas Are Covered In The Plant-Derived Analgesics Market Analysis?

The plant-derived analgesics market covered in this report is segmented –

1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin

2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils

3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals

4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets

5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain

Subsegments:

1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms

2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations

3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations

4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts

5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms

What Key Developments And Trends Are Impacting The Plant-Derived Analgesics Market?

Leading companies within the plant-derived analgesics market are prioritizing innovations in botanical extraction, purification, and formulation methods, specifically plant-based formulation and bioavailability enhancement. This strategic focus aims to minimize batch-to-batch inconsistencies and bolster both regulatory approval and consumer confidence. Plant-based formulation and bioavailability enhancement denote the precise scientific development of plant-derived analgesic products through sophisticated formulation techniques, intended to enhance the stability, solubility, and absorption of active botanical compounds, thereby ensuring more reliable product efficacy and improved therapeutic outcomes. As an illustration, in January 2023, Medterra CBD, LLC., a US-based botanical wellness company, introduced its Natural Pain Relief capsules, broadening consumer availability of plant-based pain management solutions. These Natural Pain Relief capsules are marketed as a plant-based, non-opioid option for pain management, crafted with standardized botanical ingredients such as turmeric and Levagen+ palmitoylethanolamide (PEA), with the goal of improving bioavailability and alleviating muscle pain, joint stiffness, and inflammation.

Which Key Industry Participants Are Active In The Plant-Derived Analgesics Market?

Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited

Read the full plant-derived analgesics market report here:

https://www.thebusinessresearchcompany.com/report/plant-derived-analgesics-market-report

Which Region Currently Holds The Largest Share Of The Plant-Derived Analgesics Market?

North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Plant-Derived Analgesics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33264&type=smp

Browse Through More Reports Similar to the Global Plant-Derived Analgesics Market 2026, By The Business Research Company

Analgesics Market Report 2026

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Topical Pain Relief Market Report 2026

https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the plant-derived analgesics market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Plant-Derived Analgesics Market between 2026 and 2030?

The plant-derived analgesics market has shown robust growth over recent years. It is anticipated to expand from $3.39 billion in 2025 to $3.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This expansion during the historical period is primarily due to the adoption of traditional medicine, the rising demand for natural pain relief options, increased use of herbal supplements, concerns regarding opioid side effects, and the broadening of botanical extraction processes.

The plant-derived analgesics market is projected to experience substantial growth in the coming years, reaching a valuation of $5.06 billion by 2030, driven by an 8.4% compound annual growth rate. This anticipated expansion during the forecast period is attributed to an increasing preference for natural therapeutic options, the advancement of cannabinoid medicines, an expanding pipeline of plant-based drugs, enhanced clinical validation of botanical remedies, and a broader adoption of integrative care. Key trends for the forecast period include the development of standardized botanical pain extracts, the isolation of high-purity phytochemicals, the creation of combination herbal analgesic formulations, improvements in the bioavailability of plant-derived active compounds, and the growing focus on evidence-based botanical therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33264&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Plant-Derived Analgesics Market?

The expanding occurrence of chronic pain ailments is projected to drive the future growth of the plant-derived analgesics market. These chronic pain conditions encompass persistent discomfort issues, such as musculoskeletal pain, arthritis, neuropathic pain, and inflammatory conditions, all necessitating continuous pain management. The global increase in chronic pain is attributed to factors like an aging population, inactive routines, rising obesity figures, and the increasing burden of various chronic diseases. Plant-derived analgesics aid in managing these conditions by providing pain relief solutions created from botanical extracts, herbs, and active plant compounds, which are increasingly adopted as supplementary or alternative pain management therapies. For example, in November 2024, the Centers for Disease Control and Prevention (CDC), a US-based federal public health agency, reported that roughly 24.3% of adults in the United States suffered from chronic pain in 2023, with 8.5% experiencing high-impact chronic pain. Consequently, the escalating prevalence of chronic pain conditions across significant healthcare markets is stimulating the expansion of the plant-derived analgesics market.

How Is The Plant-Derived Analgesics Market Organized Into Various Segments?

The plant-derived analgesics market covered in this report is segmented –

1) By Product Type: Morphine; Codeine; Salicin; Cannabinoids; Curcumin

2) By Formulation Type: Tablets; Capsules; Creams; Injectable Forms; Oils

3) By Source: Plant-derived opioid alkaloids; Salicylate-type analgesics; Cannabinoids And hemp-derived; Polyphenolic; Other phytochemicals

4) By Sales Channel: Hospitals; Clinics; Retail Sales; Online Sales; Hypermarkets And Supermarkets

5) By Application: Chronic Pain Management; Acute Pain Relief; Post-Surgical Pain; Neuropathic Pain

Subsegments:

1) By Morphine: Immediate Release Formulations; Extended Release Formulations; Injectable Preparations; Oral Solid Dosage Forms

2) By Codeine: Single Ingredient Analgesics; Combination Pain Relief Products; Oral Solid Dosage Forms; Liquid Oral Formulations

3) By Salicin: Standardized Plant Extracts; Oral Solid Dosage Forms; Liquid Herbal Preparations; Combination Botanical Formulations

4) By Cannabinoids: Tetrahydrocannabinol Dominant Products; Cannabidiol Dominant Products; Balanced Cannabinoid Formulations; Full Spectrum Plant Extracts

5) By Curcumin: Standard Curcumin Extracts; Enhanced Bioavailability Formulations; Combination Herbal Products; Oral Solid Dosage Forms

What Trends Are Driving The Growth Trajectory Of The Plant-Derived Analgesics Market?

Leading companies in the plant-derived analgesics market are prioritizing technological advancements in methods for botanical extraction, purification, and formulation. These include plant-based formulation and bioavailability enhancement strategies, aimed at minimizing inconsistencies between batches and boosting acceptance from regulators and consumers. Plant-based formulation and bioavailability enhancement specifically involve the scientific refinement of plant-derived analgesic products through sophisticated formulation approaches. These approaches are crafted to improve the stability, solubility, and absorption of active botanical compounds, thereby ensuring more reliable product performance and enhanced therapeutic delivery. As an illustration, in January 2023, Medterra CBD, LLC., a US-based botanical wellness company, launched its Natural Pain Relief capsules to broaden consumer access to plant-based pain management solutions. These Natural Pain Relief capsules are presented as a plant-based, non-opioid option for pain management, formulated with standardized botanical ingredients such as turmeric and Levagen+ palmitoylethanolamide (PEA), with the goal of enhancing bioavailability and supporting relief from muscle pain, joint stiffness, and inflammation.

Who Are The Top-Performing Companies In The Plant-Derived Analgesics Market In Recent Years?

Major companies operating in the plant-derived analgesics market are Dabur India Limited, Patanjali Ayurved Limited, Blackmores Limited, Bionorica SE, Emami Limited, Himalaya Wellness Company, Biologische Heilmittel Heel GmbH, Charak Pharma Private Limited, Indena S.p.A., Nature’s Way Products LLC, Arya Vaidya Sala Kottakkal, Gaia Herbs Farm Inc., Hamdard Laboratories (India), Shree Dhootapapeshwar Limited, Sri Sri Tattva, Euromed S.A., Sami-Sabinsa Group Limited, Martin Bauer Group, Shree Baidyanath Ayurved Bhawan Private Limited, Organic India Private Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/plant-derived-analgesics-market-report

Which Region Currently Holds The Largest Share Of The Plant-Derived Analgesics Market?

North America was the largest region in the plant-derived analgesics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-derived analgesics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Plant-Derived Analgesics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33264&type=smp

Browse Through More Reports Similar to the Global Plant-Derived Analgesics Market 2026, By The Business Research Company

Analgesics Market Report 2026

https://www.thebusinessresearchcompany.com/report/analgesics-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Topical Pain Relief Market Report 2026

https://www.thebusinessresearchcompany.com/report/topical-pain-relief-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model